Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes

Breast

Volumn 19, Issue 1, 2010, Pages 3-6

  Sardanelli, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Magnetic resonance imaging (MRI); Pre operative staging

Indexed keywords

ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CLINICAL DECISION MAKING; DISEASE SEVERITY; ECHOMAMMOGRAPHY; EVIDENCE BASED NURSING; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MASTECTOMY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PARTIAL BODY RADIATION; PERCUTANEOUS BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THERAPY DELAY; TREATMENT OUTCOME; TUMOR VOLUME; BREAST TUMOR; CARCINOMA; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; EVIDENCE BASED MEDICINE; FEMALE; METHODOLOGY; PATHOLOGY; PATIENT SELECTION; PREOPERATIVE CARE; REVIEW; RISK FACTOR; WOMEN'S HEALTH;

BREAST NEOPLASMS; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; PATIENT SELECTION; PREOPERATIVE CARE; RISK FACTORS; ULTRASONOGRAPHY, MAMMARY; WOMEN'S HEALTH;

EID: 77951922273     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.11.003     Document Type: Article

References (37)

1. Jatoi I., Proschan M.A. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol 2005, 28:289-294.
2. Schnall M.D., Blume J., Bluemke D.A., Deangelis G.A., Debruhl N., Harms S., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 2005, 92:32-38.
3. Sardanelli F., Giuseppetti G.M., Panizza P., Bazzocchi M., Fausto A., Simonetti G., et al. Italian trial for breast MR in multifocal/multicentric cancer. sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breast using the whole breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004, 183:1149-1157.
4. Sardanelli F., Bacigalupo L., Carbonaro L., Esseridou A., Giuseppetti G.M., Panizza P., et al. What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?. Radiol Med 2008, 113:439-451.
5. Schouten van der Velden A.P., Boetes C., Bult P., Wobbes T. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg 2006, 192:172-189.
6. Van Goethem M., Schelfout K., Kersschot E., Colpaert C., Verslegers I., Biltjes I., et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 2007, 62:273-282.
7. Kim do Y., Moon W.K., Cho N., Ko E.S., Yang S.K., Park J.S., et al. MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol 2007, 8:32-39.
8. Houssami N., Ciatto S., Macaskill P., Lord S.J., Warren R.M., Dixon J.M., et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008, 26:3248-3258.
9. Lehman C.D., Gatsonis C., Kuhl C.K., Hendrick R.E., Pisano E.D., Hanna L., et al. ACRIN Trial 6667 Investigators Group. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295-1303.
10. Brennan ME, Houssami N, Lord S, Macaskill P, Irwig L, Dixon JM, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol [published ahead of print, October 2009]. doi:10.1200/JCO.2008.21.5756.
11. Mann R.M., Hoogeveen Y.L., Blickman J.G., Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 2008, 107:1-14.
12. Kuhl C.K., Schrading S., Leutner C.C., Morakkabati-Spitz N., Wardelmann E., Fimmers R., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23:8469-8476.
13. Sardanelli F., Podo F., D'Agnolo G., Verdecchia A., Santaquilani M., Musumeci R., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007, 242:698-715.
14. Deurloo E.E., Klein Zeggelink W.F., Teertstra H.J., Peterse J.L., Rutgers E.J., Muller S.H., et al. Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients. Eur Radiol 2006, 16:692-701.
15. Al-Hallaq H.A., Mell L.K., Bradley J.A., Chen L.F., Ali A.N., Weichselbaum R.R., et al. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation. Cancer 2008, 113:2408-2414.
16. Godinez J., Gombos E.C., Chikarmane S.A., Griffin G.K., Birdwell R.L. Breast MRI in the evaluation of eligibility for accelerated partial breast irradiation. AJR Am J Roentgenol 2008, 191:272-277.
17. Tendulkar R.D., Chellman-Jeffers M., Rybicki L.A., Rim A., Kotwal A., Macklis R., et al. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation. Cancer 2009, 15(115):1621-1630.
18. Smith B.D., Arthur D.W., Buchholz T.A., Haffty B.G., Hahn C.A., Hardenbergh P.H., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74:987-1001.
19. Drew PJ, Harvey I, Hanby A, Brown S, Olivier C, Napp V, et al. The UK NIHR multicentre randomised COMICE trial of MRI planning for breast conserving treatment for breast cancer. San Antonio Breast Cancer Conference; 2008 [abstract 51].
20. Peters N.H., Borel Rinkes I.H., Mali W.P., van den Bosch M.A., Storm R.K., Plaisier P.W., et al. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome - MONET - study. Trials 2007, 28(8):40.
21. Fischer U., Zachariae O., Baum F., von Heyden D., Funke M., Liersch T. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14:1725-1731.
22. Solin L.J., Orel S.G., Hwang W.T., Harris E.E., Schnall M.D. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26:386-391.
23. Pengel K.E., Loo C.E., Teertstra H.J., Muller S.H., Wesseling J., Peterse J.L., et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 2009, 116:161-169.
24. Bleicher R.J., Ciocca R.M., Egleston B.L., Sesa L., Evers K., Sigurdson E.R., et al. The influence of routine pretreatment MRI on time to treatment, mastectomy rate and positive margins. ASCO Breast 2008, [abstract 227].
25. Pleijhuis R.G., Graafland M., de Vries J., Bart J., de Jong J.S., van Dam G.M. Obtaining adequate surgical margins in breast-Conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol 2009 Jul 17, [Epub ahead of print].
26. Houssami N., Hayes D.F. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI Be performed on all women with newly diagnosed, early stage breast cancer?. CA Cancer J Clin 2009, 59:290-302.
27. Veronesi U., Cascinelli N., Mariani L., Greco M., Saccozzi R., Luini A., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
28. Adami H.O., Bergstrom R., Hansen J. Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case control study. Cancer 1985, 55:643-647.
29. Rutqvist L.E., Cedermark B., Glas U., Mattsson A., Skoog L., Somell A., et al. Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 1991, 83:1299-1306.
30. Foote R.L., Johnson R.E., Donohue J.H., Wahner-Roedler D.L., Grant C.S., Petersen I.A., et al. Trends in surgical treatment of breast cancer at Mayo Clinic 1980-2004. Breast 2008, 17:555-562.
31. Katipamula R., Hoskin T.L., Boughey J.C., Degnim A.C., Grant C.S., Brandt K.R., et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative MRI. J Clin Oncol 2008, 26. [May 20 suppl; abstr 509].
32. Wijayanayagam A., Kumar A.S., Foster R.D., Esserman L.J. Optimizing the total skin-sparing mastectomy. Arch Surg 2008, 143:38-45.
33. Frei K.A., Bonel H.M., Pelte M.F., Hylton N.M., Kinkel K. Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation. Invest Radiol 2005, 40:363-367.
34. Haddad N., Ollivier L., Tardivon A., Thibault F., El Khoury C., Neuenschwander S. Usefulness of magnetic resonance imaging in Paget disease of the breast. J Radiol 2007, 88:579-584.
35. Morrogh M., Morris E.A., Liberman L., Van Zee K., Cody H.S., King T.A., et al. MRI identifies otherwise occult disease in select patients with Paget disease of the nipple. J Am Coll Surg 2008, 206:316-321.
36. Sackett D.L., Rosenberg W.M., Gray J.A., Haynes R.B., Richardson W.S. Evidence based medicine: what it is and what it isn't. BMJ 1996, 312:71-72.
37. Clarke M., Collins R., Darby S., Davies C., Elphinstone P., Evans E., et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106.